The DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.
Is the Prevalence of Metabolic Syndrome and Metabolic Abnormalities Increased in Early Schizophrenia? A Comparative Meta-Analysis of First Episode, Untreated and Treated Patients
Open accessAbstract
UNLABELLED: We aimed to discover whether metabolic complications of schizophrenia (SZ) are present in first episode (FE) and unmedicated (UM) patients, in comparison with patients established on antipsychotic medication (AP). METHOD: A systematic search, critical appraisal, and meta-analysis were conducted of studies to December 2011 using Medline, PsycINFO, Embase and experts. Twenty-six studies examined FE SZ patients (n = 2548) and 19 included UM SZ patients (n = 1325). For comparison we identified 78 publications involving 24 892 medicated patients who had chronic SZ already established on AP. RESULTS: In UM, the overall rate of metabolic syndrome (MetS) was 9.8% using any standardized criteria. Diabetes was found in only 2.1% and hyperglycaemia (>100 mg/dl) in 6.4%. In FE, the overall MetS rate was 9.9%, diabetes was found in only 1.2%, and hyperglycaemia in 8.7%. In UM and FE, the rates of overweight were 26.6%, 22%; hypertriglyceridemia 16.9%, 19.6%; low HDL 20.4%, 21.9%; high blood pressure 24.3%, 30.4%; smoking 40.2%, 46.8%, respectively. In both groups all metabolic components and risk factors were significantly less common in early SZ than in those already established on AP. Waist size, blood pressure and smoking were significantly lower in UM compared with FE. CONCLUSION: There is a significantly lower cardiovascular risk in early SZ than in chronic SZ. Both diabetes and pre-diabetes appear uncommon in the early stages, especially in UM. However, smoking does appear to be elevated early after diagnosis. Clinicians should focus on preventing initial cardiometabolic risk because subsequent reduction in this risk is more difficult to achieve, either through behavioral or pharmacologic interventions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & The PRISMA Group (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000097 · Cited by 64,042
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
(2009) · PubMed Central · Cited by 44,859
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Moher, D., Liberati, A., Tetzlaff, J., & Altman, D. G. (2009) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2009.06.005 · Cited by 19,575
Grundy, S. M., Cleeman, J. I., Daniels, S. R., Donato, K. A., Eckel, R. H., Franklin, B. A., Gordon, D. J., Krauss, R. M., Savage, P. J., Smith, S. C., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.169404 · Cited by 11,961
The metabolic syndrome—a new worldwide definition
Alberti, K. G. M., Zimmet, P., & Shaw, J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67402-8 · Cited by 9,352
Alberti, K. G. M. M., Zimmet, P., & Shaw, J. (2006) · Diabetic Medicine · doi:10.1111/j.1464-5491.2006.01858.x · Cited by 6,597
The Metabolic Syndrome and Cardiovascular Risk
Mottillo, S., Filion, K. B., Genest, J., Joseph, L., Pilote, L., Poirier, P., Rinfret, S., Schiffrin, E. L., & Eisenberg, M. J. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.05.034 · Cited by 3,009
DE HERT, M., CORRELL, C. U., BOBES, J., CETKOVICH‐BAKMAS, M., COHEN, D., ASAI, I., DETRAUX, J., GAUTAM, S., MÖLLER, H., NDETEI, D. M., et al. (2011) · World Psychiatry · doi:10.1002/j.2051-5545.2011.tb00014.x · Cited by 2,488
Saha, S., Chant, D., & McGrath, J. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.10.1123 · Cited by 2,065
Second-Generation (Atypical) Antipsychotics and Metabolic Effects: A Comprehensive Literature Review
Newcomer, J. W. (2005) · CNS Drugs · doi:10.2165/00023210-200519001-00001 · Cited by 1,340
Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population
Cowie, C. C., Rust, K. F., Byrd-Holt, D. D., Eberhardt, M. S., Flegal, K. M., Engelgau, M. M., Saydah, S. H., Williams, D. E., Geiss, L. S., & Gregg, E. W. (2006) · Diabetes Care · doi:10.2337/dc06-0062 · Cited by 1,210
Metabolic and cardiovascular adverse effects associated with antipsychotic drugs.
De Hert, M., Detraux, J., van Winkel, R., Yu, W., & Correll, C. U. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.156 · Cited by 1,145
Kahn, R. S., Fleischhacker, W. W., Boter, H., Davidson, M., Vergouwe, Y., Keet, I. P., Gheorghe, M. D., Rybakowski, J. K., Galderisi, S., Libiger, J., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60486-9 · Cited by 1,088
Causes of the excess mortality of schizophrenia
Brown, S., Inskip, H., & Barraclough, B. (2000) · British Journal of Psychiatry · doi:10.1192/bjp.177.3.212 · Cited by 1,087
Mitchell, A. J., Vancampfort, D., Sweers, K., van Winkel, R., Yu, W., & De Hert, M. (2013) · Schizophrenia Bulletin · doi:10.1093/schbul/sbr148 · Cited by 1,082
Self-citationDe Hert, M., Dekker, J. M., Wood, D., Kahl, K. G., Holt, R. I. G., & Möller, H.-J. (2009) · European Psychiatry · doi:10.1016/j.eurpsy.2009.01.005 · Cited by 951
DE HERT, M., COHEN, D., BOBES, J., CETKOVICH‐BAKMAS, M., LEUCHT, S., NDETEI, D. M., NEWCOMER, J. W., UWAKWE, R., ASAI, I., MÖLLER, H., et al. (2011) · World Psychiatry · doi:10.1002/j.2051-5545.2011.tb00036.x · Cited by 870
Excess mortality of schizophrenia: A meta-analysis
Brown, S. (1997) · British Journal of Psychiatry · doi:10.1192/bjp.171.6.502 · Cited by 869
Impaired Fasting Glucose Tolerance in First-Episode, Drug-Naive Patients With Schizophrenia
Ryan, M. C. M., Collins, P., & Thakore, J. H. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.2.284 · Cited by 828
Physical Health Monitoring of Patients With Schizophrenia
Marder, S. R., Essock, S. M., Miller, A. L., Buchanan, R. W., Casey, D. E., Davis, J. M., Kane, J. M., Lieberman, J. A., Schooler, N. R., Covell, N., et al. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.8.1334 · Cited by 812
Size of burden of schizophrenia and psychotic disorders
Rössler, W., Joachim Salize, H., van Os, J., & Riecher-Rössler, A. (2005) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2005.04.009 · Cited by 741
Rummel-Kluge, C., Komossa, K., Schwarz, S., Hunger, H., Schmid, F., Lobos, C. A., Kissling, W., Davis, J. M., & Leucht, S. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.07.012 · Cited by 675
Metabolic syndrome in people with schizophrenia: a review
DE HERT, M., SCHREURS, V., VANCAMPFORT, D., & VAN WINKEL, R. (2009) · World Psychiatry · doi:10.1002/j.2051-5545.2009.tb00199.x · Cited by 634
Self-citationTwenty-five year mortality of a community cohort with schizophrenia
Brown, S., Kim, M., Mitchell, C., & Inskip, H. (2010) · British Journal of Psychiatry · doi:10.1192/bjp.bp.109.067512 · Cited by 601
Life expectancy among persons with schizophrenia or bipolar affective disorder
Laursen, T. M. (2011) · Schizophrenia Research · doi:10.1016/j.schres.2011.06.008 · Cited by 508
Obesity as a risk factor for antipsychotic noncompliance
Weiden, P. J., Mackell, J. A., & McDonnell, D. D. (2004) · Schizophrenia Research · doi:10.1016/s0920-9964(02)00498-x · Cited by 433
Antipsychotic medications: metabolic and cardiovascular risk.
Newcomer, J. W. (2007) · PubMed · Cited by 416
McEvoy, J. P., Lieberman, J. A., Perkins, D. O., Hamer, R. M., Gu, H., Lazarus, A., Sweitzer, D., Olexy, C., Weiden, P., & Strakowski, S. D. (2007) · American Journal of Psychiatry · doi:10.1176/ajp.2007.164.7.1050 · Cited by 377
Mortality in a Cohort of Patients with Schizophrenia: A Record Linkage Study*
Newman, S. C., & Bland, R. C. (1991) · The Canadian Journal of Psychiatry · doi:10.1177/070674379103600401 · Cited by 371
De Hert, M., Dobbelaere, M., Sheridan, E. M., Cohen, D., & Correll, C. U. (2011) · European Psychiatry · doi:10.1016/j.eurpsy.2010.09.011 · Cited by 362
Self-citationMitchell, A. J., Delaffon, V., Vancampfort, D., Correll, C. U., & De Hert, M. (2012) · Psychological Medicine · doi:10.1017/s003329171100105x · Cited by 332
Self-citationImpaired glucose tolerance in first‐episode drug‐naïve patients with schizophrenia
Spelman, L. M., Walsh, P. I., Sharifi, N., Collins, P., & Thakore, J. H. (2007) · Diabetic Medicine · doi:10.1111/j.1464-5491.2007.02092.x · Cited by 318
Ford, E. S., & Li, C. (2008) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2007.07.056 · Cited by 313
Systematic Review of Early Cardiometabolic Outcomes of the First Treated Episode of Psychosis
Foley, D. L., & Morley, K. I. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.2 · Cited by 287
Álvarez-Jiménez, M., González-Blanch, C., Crespo-Facorro, B., Hetrick, S., Rodríguez-Sánchez, J. M., Pérez-Iglesias, R., & Vázquez-Barquero, J. L. (2008) · CNS Drugs · doi:10.2165/00023210-200822070-00002 · Cited by 264
Maayan, L., & Correll, C. U. (2011) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2011.0015 · Cited by 252
Physical consequences of schizophrenia and its treatment
Ryan, M. C. M., & Thakore, J. H. (2002) · Life Sciences · doi:10.1016/s0024-3205(02)01646-6 · Cited by 251
De Hert, M., Schreurs, V., Sweers, K., Van Eyck, D., Hanssens, L., Šinko, S., Wampers, M., Scheen, A., Peuskens, J., & van Winkel, R. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2008.01.028 · Cited by 247
Self-citationArterial Stiffness and Stroke in Hypertension: Therapeutic Implications for Stroke Prevention
Laurent, S., & Boutouyrie, P. (2005) · CNS Drugs · doi:10.2165/00023210-200519010-00001 · Cited by 236
Time trends in schizophrenia mortality in Stockholm county, Sweden: cohort study
Osby, U. (2000) · BMJ · doi:10.1136/bmj.321.7259.483 · Cited by 220
De Hert, M., Vancampfort, D., Correll, C. U., Mercken, V., Peuskens, J., Sweers, K., van Winkel, R., & Mitchell, A. J. (2011) · British Journal of Psychiatry · doi:10.1192/bjp.bp.110.084665 · Cited by 217
Self-citationNielsen, J., Skadhede, S., & Correll, C. U. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.78 · Cited by 207
Capasso, R. M., Lineberry, T. W., Bostwick, J. M., Decker, P. A., & St. Sauver, J. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2007.10.005 · Cited by 199
Stroup, T. S., McEvoy, J. P., Ring, K. D., Hamer, R. H., LaVange, L. M., Swartz, M. S., Rosenheck, R. A., Perkins, D. O., Nussbaum, A. M., Lieberman, J. A., et al. (2011) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2011.10111609 · Cited by 193
Bobes, J., Arango, C., Garcia-Garcia, M., & Rejas, J. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.02.1030 · Cited by 181
Diabetes mellitus and schizophrenia: Historical perspective
Kohen, D. (2004) · British Journal of Psychiatry · doi:10.1192/bjp.184.47.s64 · Cited by 181
Álvarez-Jiménez, M., González-Blanch, C., Vázquez-Barquero, J. L., Pérez-Iglesias, R., Martínez-García, O., Pérez-Pardal, T., Ramírez-Bonilla, M. L., & Crespo-Facorro, B. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n0812 · Cited by 180
Nutritional Assessment of Patients With Schizophrenia: A Preliminary Study
Strassnig, M., Brar, J. S., & Ganguli, R. (2003) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a007013 · Cited by 174
Arranz, B., Rosel, P., Ramírez, N., Dueñas, R., Fernández, P., Sanchez, J. M., Navarro, M. A., & San, L. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n1007 · Cited by 161
Vancampfort, D., Knapen, J., Probst, M., van Winkel, R., Deckx, S., Maurissen, K., Peuskens, J., & Binder, M. D. (2010) · Psychiatry Research · doi:10.1016/j.psychres.2010.03.011 · Cited by 157
Self-citationAtypical Depression: A Valid Subtype?
Parker, G. B., & Thase, M. E. (2007) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.0307e08 · Cited by 145
Metabolic Syndrome Associated with Schizophrenia and Atypical Antipsychotics
Hasnain, M., Fredrickson, S. K., Vieweg, W. V. R., & Pandurangi, A. K. (2010) · Current Diabetes Reports · doi:10.1007/s11892-010-0112-8 · Cited by 133
Metabolic Risk Factors in Drug-Naive Patients With First-Episode Psychosis
Verma, S. K., Subramaniam, M., Liew, A., & Poon, L. Y. (2009) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.08m04508 · Cited by 132
Fakhoury, W. K. H., Wright, D., & Wallace, M. (2001) · International Clinical Psychopharmacology · doi:10.1097/00004850-200105000-00004 · Cited by 127
Mukundan, A., Faulkner, G., Cohn, T. A., & Remington, G. J. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006629.pub2 · Cited by 124
Sengupta, S. M., Parrilla-Escobar, M. A., Klink, R., Fathalli, F., Ng, Y. K., Stip, É., Baptista, T., MALLA, A. K., & Joober, R. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2008.02.013 · Cited by 121
Weight gain in antipsychotic-naive patients: a review and meta-analysis
Tarricone, I., Gozzi, B. F., Serretti, A., Grieco, D., & Berardi, D. (2009) · Psychological Medicine · doi:10.1017/s0033291709990407 · Cited by 114
Vancampfort, D., Probst, M., Scheewe, T., Maurissen, K., Sweers, K., Knapen, J., & De Hert, M. (2011) · Schizophrenia Research · doi:10.1016/j.schres.2011.03.018 · Cited by 113
Self-citationBalancing Efficacy and Safety in Treatment with Antipsychotics
Correll, C. U. (2007) · CNS Spectrums · doi:10.1017/s1092852900026298 · Cited by 103
Body weight and self-esteem in patients with schizophrenia evaluated with B-WISE®
Binder, M. D., Peuskens, B., van Winkel, R., Kalnická, D., Hanssens, L., Eyck, D. V., Wyckaert, S., & Peuskens, J. (2006) · Schizophrenia Research · doi:10.1016/j.schres.2006.07.025 · Cited by 91
Vancampfort, D., Sweers, K., Probst, M., Maurissen, K., Knapen, J., Minguet, P., & Hert, M. A. F. D. (2011) · Diabetes & Metabolism · doi:10.1016/j.diabet.2010.12.007 · Cited by 80
Self-citationKoivukangas, J., Tammelin, T., Kaakinen, M., Maki, P. M., Moilanen, I., Taanila, A. M., & Veijola, J. M. (2009) · Schizophrenia Research · doi:10.1016/j.schres.2009.10.022 · Cited by 80
Cardiometabolic effects of physical activity interventions for people with schizophrenia
Vancampfort, D., Knapen, J., Binder, M. D., van Winkel, R., Deckx, S., Maurissen, K., Peuskens, J., Simons, J., & Probst, M. (2009) · Physical Therapy Reviews · doi:10.1179/108331909x12540993898053 · Cited by 79
Self-citationKirkpatrick, B. W., Miller, B. J., García‐Rizo, C., Fernández-Egea, E., & Bernardo, M. (2010) · Schizophrenia Bulletin · doi:10.1093/schbul/sbq058 · Cited by 76
Cardiovascular risk in a first-episode psychosis sample: A ‘critical period’ for prevention?
Phutane, V. H., Tek, C., Chwastiak, L., Ratliff, J. C., Ozyüksel, B., Woods, S. W., & Srihari, V. H. (2011) · Schizophrenia Research · doi:10.1016/j.schres.2010.12.008 · Cited by 68
van Winkel, R., Moons, T., Peerbooms, O., Rutten, B. P. F., Peuskens, J., Claes, S. J., van Os, J., & Binder, M. D. (2010) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e32833bc60d · Cited by 65
Graham, K. A., Cho, H., Brownley, K. A., & Harp, J. B. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2007.12.476 · Cited by 58
[Mortality in schizophrenic patients. 3 years follow-up of a cohort].
Casadebaig, F., & Philippe, A. (1999) · PubMed · Cited by 45
Gaal, L. F. V. (2006) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2006.06.005 · Cited by 42
Distress with Medication Side Effects among Persons with Severe Mental Illness
Covell, N. H., Weissman, E. M., Schell, B., McCorkle, B. H., Summerfelt, W. T., Weiden, P. J., & Essock, S. M. (2007) · Administration and Policy in Mental Health and Mental Health Services Research · doi:10.1007/s10488-007-0131-1 · Cited by 29
Cohen, D., & Binder, M. D. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.94 · Cited by 27
Juutinen, J., Hakko, H. H., Meyer‐Rochow, V. B., Räsänen, P. K., & Timonen, M. (2008) · European Psychiatry · doi:10.1016/j.eurpsy.2008.06.002 · Cited by 12
Hert, M. D., Vancampfort, D., Correll, C. U., Peuskens, J., van Winkel, R., & Mitchell, A. J. (2011) · European Psychiatry · doi:10.1016/s0924-9338(11)73892-5 · Cited by 8
Self-citation
Cited by
Firth, J., Siddiqi, N., Koyanagi, A., Siskind, D., Rosenbaum, S., Galletly, C., Allan, S., Caneo, C., Carney, R., Carvalho, A. F., et al. (2019) · The Lancet Psychiatry · doi:10.1016/s2215-0366(19)30132-4 · Cited by 1,531
Self-citationVancampfort, D., Stubbs, B., Mitchell, A. J., De Hert, M., Wampers, M., Ward, P. B., Rosenbaum, S., & Correll, C. U. (2015) · World Psychiatry · doi:10.1002/wps.20252 · Cited by 1,271
Self-citationCorrell, C. U., Detraux, J., De Lepeleire, J., & De Hert, M. (2015) · World Psychiatry · doi:10.1002/wps.20204 · Cited by 820
“Recently, metaanalyses (16,56) showed that the prevalence of DM is not appreciably increased in drug-na€ıve patients during the first episode of psychosis once control groups are age-matched.”
BackgroundImpaired Glucose Homeostasis in First-Episode Schizophrenia: A Systematic Review and Meta-analysis
Pillinger, T., Beck, K., Gobjila, C., Donocik, J. G., Jauhar, S., & Howes, O. D. (2017) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2016.3803 · Cited by 457
Correll, C. U., Robinson, D. G., Schooler, N. R., Brunette, M. F., Mueser, K. T., Rosenheck, R. A., Marcy, P., Addington, J., Estroff, S. E., Robinson, J., et al. (2014) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.1314 · Cited by 384
Metadata
- Authors
- Mitchell, A. J., Vancampfort, D., De Herdt, A., Yu, W., & De Hert, M.
- Venue
- Schizophrenia Bulletin
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-08-27
- Volume
- 39
- Issue
- 2
- Pages
- 295-305
- ISSN
- 0586-7614 (ISSN-L)
- 1745-1701
- OpenAlex
- W2110896761
- Cited by
- 327
- References
- 77
- FWCI
- 2.86
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.